Search Results

Pictured: Office building science collage

Career Advice

The Top 12 Companies Hiring in Biopharma Now

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you.

February 6, 2025

·

1 min read

·

Angela Gabriel

NextGen

BioSpace’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends

From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.

January 7, 2025

·

5 min read

·

Heather McKenzie

Illustration of two hands shaking while another hand gently grips a wrist

Collaboration

The Top 7 Biopharma Licensing Deals of 2024

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their pipelines with novel and potentially more effective therapies.

February 5, 2025

·

8 min read

·

Tristan Manalac

Press Releases

Rosalind Franklin University’s Helix 51 Incubator Welcomes Monopar Therapeutics

Monopar’s pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease

January 23, 2025

·

1 min read

Halftone collage banner, palm and magic glass ball floating in the air on a dark background. Magic clouds, stars, pop art poster.

Deals

The Biopharma Crystal Ball Comes Out at JPM25

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea for the slow, healthy recovery of the industry at large.

January 17, 2025

·

3 min read

·

Annalee Armstrong

Sketch of people teamwork, gears, production. Doodle cartoon mechanism with machinery and cogwheels. Hand drawn vector illustration for business and industry design isolated on white.

Manufacturing

Biopharma’s Big Question of 2024: Can You Scale It?

Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of pharma is going to be vying for capacity and talent.

December 18, 2024

·

5 min read

·

Annalee Armstrong

As a result of the economic problems, the company lacked liquidity and closed down

Layoffs

Layoffs Continued Across Biopharma in 2024

While layoffs slowed in the second half of 2024, biopharmas including Bayer, Bristol Myers Squibb and Johnson & Johnson cut hundreds or even thousands of employees over the course of the year.

December 31, 2024

·

130 min read

·

BioSpace Editorial Staff

View of traffic on the Bay Bridge with downtown San Francisco and stormy sky in background

Mergers & acquisitions

Biopharma Heads to JP Morgan Seeking an M&A Spark to Improve Sentiment

M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next week in a grim mood.

January 6, 2025

·

5 min read

·

Annalee Armstrong

Venture capitalists

The Megaround Ruled Biopharma in 2024 as First-Time VC Funding Doubled

Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 deals in 2023.

January 9, 2025

·

2 min read

·

Annalee Armstrong

North view of the White House, with waving flag and cloudy sky, on a reflective surface that could be glass or water. 3D Illustration

Government

WHO Withdrawal, CGT Access, IRA: Trump’s Initial Policies Raise Questions for Biopharma

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, President Trump issued multiple executive orders that concern the industry.

January 22, 2025

·

5 min read

·

Annalee Armstrong